Memry — Westergaard Conference Webcast November 2007
24 slides from Memry's conference presentation, Nov 13, 2007
Slide 1: Westergaard Conference Webcast November 2007
MIEMRY Westergaard Conference Webcast November 2007
Slide 2: Forward-looking statements
This presentation contains certain forward-looking statements which involve known and unknown risks, uncertainties or other factors not under the Company’s control which may cause actual results, performance or achievements of the Company to be materially different from the results, performance, or
Slide 3: Compelling Value Proposition
Compelling Value Proposition Innovative, Strategic Technology Solutions Large and Growing Medical Device Market Strong Growing Pipeline Strong Balance Sheet Strong Cash Generator Building Momentum Trading Near Book Value
Slide 4: Enabling minimally invasive and targeted therapies for the medical industry
“Enabling minimally invasive and targeted therapies for the medical industry”
Slide 5: Materials & Processes Enabling Properties (Nitinol)
Materials & Processes Enabling Properties Superelastic & Shape Kink resistance Memory Nitinol Alloys Crush resistance Ability to recover large Wire & Tube Drawing deformation ; Thermal Recovery Laser Cutting Confined Access & Delivery Stent Manufacturing Wire Forming Surface Finishing Grinding & Coa
Slide 6: Materials & Processes Enabling Properties (Polymers)
Materials & Processes Enabling Properties Custom Co-Extruded Multi Layer Polymer Components Multi Lumen pep aetnenes Coil and Braid Reinforcement hems Thin Wall Polyesters . Fluoropolymers Jacketing Polyimides Radiopacity Tipping & Forming Tapering Grinding Braiding & Coiling Catheter-based Minimall
Slide 7: Surgical Devices & Instruments
78.3% Surgical Devices & Instruments ™ Orthopaedics Monitoring/Imaging ™ Surgery/Endosurgery Electrosurgical/ Auxiliary Equipment Cardiovascular/Thoracic Robotics (Source: BCC Research, June 2006)
Slide 8: Improving Quality of Healthcare
Improving Quality of Healthcare Aging Population Stringent Regulatory Environment Competition & Speed to Market External Drivers Cost Containment Product Innovation & Technology Mergers & Acquisitions Globalization Vendor Base Consolidation Millennium Research Group, October 2005
Slide 9: Device OEMs want to focus on R&D, Technology, Sales & Marketing
Device OEMs want to focus on R&D, Technology, Sales & Marketing, Distribution and Regulatory Issues Device companies outsource for a variety of reasons Reduce operating costs Expand their portfolio of capabilities Simplify supply chain logistics Reduce capital expenditures Larger, full-service suppl
Slide 10: Full Suite of Capabilities
Full Suite of Capabilities Supply Chain Management Technology Leadership Rapid Turnaround Quality & Competitive Pricing Device Application Knowledge Globalization
Slide 11: Management team
Robert Belcher, Chief Executive Officer Dean Tulumaris, President & Chief Operating Officer Richard Sowerby, Chief Financial Officer & Treasurer Philippe Poncet, Vice President Business Development Marcy Macdonald, Vice President Human Resources
Slide 12: oF . AR :
oF . AR :
Slide 13: Orthopedics
Slide 14: Vascular/Radiology
Slide 15: Neurology
Neurology/ |
Slide 16: Coronary & EP
Coronary & EP |
Slide 17: Urology/OBGyn
Urology/OBGyn @ |
Slide 18: Ophthalmology / ENT
( a Ophthalmology ENT
Slide 19: Clinical areas served
Neurology). ) Ophthalmolo: ENT@ug P ay Corénary &EP @ Vas¢ular/Radiglogy ( } | Endosurgery e 74 UrolggyiOBGyn | } | ey Orthopaedics
Slide 20: High-end Processing Technologies
High-end Processing Technologies Passive and Biointeractive Medical Polymers & Biomaterials Materials, Processes & Product Integration Surface Modification & Finishing Technologies Integration Technologies Critical to Complete Product capability 4 Market Leadership & Recognition as Leading Provider
Slide 21: FY 2007, FY 2006, FY 2005 results
FY 2007. FY 2006 FY 2005 Revenues $51.7M $52.6M $45.0M Gross Margin 32% 39% 40% Net Income $0.3May. $2.7Ma») $2.7M. Total Debt $1.6 $10.0 $11.4 Debt/Capital 4% 20% 24% a) Includes pre-tax incremental fees for litigation and professional fees for litigation defense and the implementation of Sarbanes-
Slide 22: Consolidated Revenues & Gross Margin
Consolidated Revenues & Gross Margin By Quarter 2005 - 2008 Revenue
Slide 23: Cash Flow From Operating Activities
. ee Fiscal Year Three Months Ended ash Flow From Operating Activities: 2006 2007 09/30/06 _ 09/30/07 o A Net income $2.7 $0.3 $1.0 $0.4 Adjustments to reconcile net income to net NN cash provided by operating activities: Depreciation and amortization 2.9 3.2 0.8 Deferred income taxes 1.4 0.2 0.6 St
Slide 24: Compelling Value Proposition
Compelling Value Proposition Innovative, Strategic Technology Solutions Large and Growing Medical Device Market Strong Growing Pipeline Strong Balance Sheet Strong Cash Generator Building Momentum Trading Near Book Value